Table I.
miR-122-5p expression | ||||
---|---|---|---|---|
Characteristics | Cases | Low | High | P-value |
Total | 45 | 23 | 22 | |
Sex | 0.5589 | |||
Male | 12 | 7 | 5 | |
Female | 33 | 16 | 17 | |
Age, years | 0.3666 | |||
≥65 | 20 | 13 | 7 | |
<65 | 25 | 12 | 13 | |
CDFI classification grade | 0.0080a | |||
I | 28 | 10 | 18 | |
II–III | 17 | 13 | 4 | |
Degree of invasion | 0.0018a | |||
Intrathyroid | 22 | 6 | 16 | |
Extrathyroid | 23 | 17 | 6 | |
PTC diameter, cm | 0.0001a | |||
≥3.0 | 27 | 21 | 6 | |
<3.0 | 18 | 2 | 16 | |
Pathological stage (T) | 0.0027a | |||
T2 | 24 | 7 | 17 | |
T3-T4 | 21 | 16 | 5 | |
Pathological stage (N) | 0.0305a | |||
N0 | 32 | 12 | 20 | |
N1 | 13 | 11 | 2 | |
Outcome | 0.2150 | |||
Persistent/recurrent | 2 | 2 | 0 | |
Death | 1 | 1 | 0 | |
Cured | 42 | 20 | 22 |
miR-122-5p median expression level was used as the cut-off. P-values were acquired using Pearson's chi-square test.
P<0.05 miR, microRNA; PTC, papillary thyroid carcinoma.